CYYNF (Cynata Therapeutics) Other Current Liabilities: $0.18 Mil (As of Dec. 2025)


What is Cynata Therapeutics Other Current Liabilities?

Cynata Therapeutics CYYNF Other Current Liabilities is $0.18 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Cynata Therapeutics's other current liabilities for the quarter that ended in Dec. 2025 was $0.18 Mil.

Cynata Therapeutics's quarterly other current liabilities increased from Dec. 2024 ($0.15 Mil) to Jun. 2025 ($0.18 Mil) and increased from Jun. 2025 ($0.18 Mil) to Dec. 2025 ($0.18 Mil).

Cynata Therapeutics's annual other current liabilities increased from Jun. 2023 ($0.13 Mil) to Jun. 2024 ($0.15 Mil) and increased from Jun. 2024 ($0.15 Mil) to Jun. 2025 ($0.18 Mil).

Cynata Therapeutics Other Current Liabilities Related Terms

Cynata Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Cynata Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cynata Therapeutics Other Current Liabilities Chart

Cynata Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.18 0.13 0.15 0.18

Cynata Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.15 0.15 0.18 0.18

Cynata Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.18 Mil mean?
Cynata Therapeutics (CYYNF) has a Other Current Liabilities of $0.18 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cynata Therapeutics.
Is Cynata Therapeutics' Other Current Liabilities too high?
Cynata Therapeutics' current Other Current Liabilities is $0.18 Mil.
How does Cynata Therapeutics' Other Current Liabilities compare to VRTX and REGN?
Cynata Therapeutics' Other Current Liabilities of $0.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cynata Therapeutics. Cynata Therapeutics's current Other Current Liabilities is $0.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cynata Therapeutics stock overvalued right now?
Cynata Therapeutics (CYYNF) has a current Other Current Liabilities of $0.18 Mil. The current Other Current Liabilities is $0.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Cynata Therapeutics (CYYNF), the current Other Current Liabilities is $0.18 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cynata Therapeutics Business Description

Other Exchanges 51S:GermanyCYP:Australia
Address 100 Cubitt Street, Level 3, Cremorne, VIC, AUS, 3121
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus manufacturing platform. There are currently three active clinical trials taking place using Cymerus technology, which are attempting to treat osteoarthritis and others.